Charles River Laboratories Partners With Akron Bio to Improve Cancer Treatment Platforms

MT Newswires Live

01-17

Charles River Laboratories (CRL) and Akron Bio said Thursday they integrated Akron's current Closed System Solutions liquid cytokines into Charles River's Cell Therapy Flex Platform to improve cancer treatment platform.

Using closed systems can simplify the production process, minimize risk, and boost the overall reliability of cell therapy manufacturing, the company said.

Adding liquid cytokines to the Flex Platform could reduce labor requirements, strengthen processes, and ultimately lower risks for patients, Charles River's Senior Vice President Kerstin Dolph added.

Price: 165.26, Change: -8.65, Percent Change: -4.97

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2504946234"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2504946234\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2504946234?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-17 02:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2504946234","market":"nz","top_or_hot":-1,"title":"Charles River Laboratories Partners With Akron Bio to Improve Cancer Treatment Platforms","media":"MT Newswires Live","content":"<html><body><p> Charles River Laboratories (CRL) and Akron Bio said Thursday they integrated Akron's current Closed System Solutions liquid cytokines into Charles River's Cell Therapy Flex Platform to improve cancer treatment platform.</p><p>Using closed systems can simplify the production process, minimize risk, and boost the overall reliability of cell therapy manufacturing, the company said.</p><p>Adding liquid cytokines to the Flex Platform could reduce labor requirements, strengthen processes, and ultimately lower risks for patients, Charles River's Senior Vice President Kerstin Dolph added.</p><p>Price: 165.26, Change: -8.65, Percent Change: -4.97</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Charles River Laboratories Partners With Akron Bio to Improve Cancer Treatment Platforms</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCharles River Laboratories Partners With Akron Bio to Improve Cancer Treatment Platforms\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-01-17 02:39</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Charles River Laboratories (CRL) and Akron Bio said Thursday they integrated Akron's current Closed System Solutions liquid cytokines into Charles River's Cell Therapy Flex Platform to improve cancer treatment platform.</p><p>Using closed systems can simplify the production process, minimize risk, and boost the overall reliability of cell therapy manufacturing, the company said.</p><p>Adding liquid cytokines to the Flex Platform could reduce labor requirements, strengthen processes, and ultimately lower risks for patients, Charles River's Senior Vice President Kerstin Dolph added.</p><p>Price: 165.26, Change: -8.65, Percent Change: -4.97</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4121","symbol_name":"生命科學工具和服務","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2504946234","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2504946234","pubTimestamp":1737052754,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Charles River Laboratories  and Akron Bio said Thursday they integrated Akron's current Closed System Solutions liquid cytokines into Charles River's Cell Therapy Flex Platform to improve cancer treatment platform.Using closed systems can simplify the production process, minimize risk, and boost the overall reliability of cell therapy manufacturing, the company said.Adding liquid cytokines to the Flex Platform could reduce labor requirements, strengthen processes, and ultimately lower risks for patients, Charles River's Senior Vice President Kerstin Dolph added.Price: 165.26, Change: -8.65, Percent Change: -4.97","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4121":"生命科学工具和服务","CRL":"查尔斯河","BK4588":"碎股","BK4530":"医药外包概念","LU0390134368.USD":"FRANKLIN GLOBAL GROWTH \"A\" (USD) ACC","BK7095":"多种金属与采矿","BK4585":"ETF&股票定投概念","CRL.AU":"Comet Resources Ltd"},"translate_title":"Charles River Laboratories与Akron Bio合作改进癌症治疗平台","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CRL":1,"CRL.AU":1},"content_text":"Charles River Laboratories (CRL) and Akron Bio said Thursday they integrated Akron's current Closed System Solutions liquid cytokines into Charles River's Cell Therapy Flex Platform to improve cancer treatment platform.Using closed systems can simplify the production process, minimize risk, and boost the overall reliability of cell therapy manufacturing, the company said.Adding liquid cytokines to the Flex Platform could reduce labor requirements, strengthen processes, and ultimately lower risks for patients, Charles River's Senior Vice President Kerstin Dolph added.Price: 165.26, Change: -8.65, Percent Change: -4.97","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1}}}